Register
Login:
Share:
Email Facebook Twitter




Quick Poll
QUICK POLL >
Do you transfer money abroad?




Add Verona Pharma to quick picks

Verona Pharma Share Price (VRP)



Share Price Information for Verona Pharma (VRP)


Share Price: 3.40Bid: 3.30Ask: 3.50Change: 0.00 (0.00%)No Movement on Verona Pharma
Spread: 0.20Spread as %: 6.06%Open: 3.45High: 3.45Low: 3.40Yesterday’s Close: 3.40
InfoCFDs vs Share Trading - Download your Free Guide from London South East Markets
When trading CFDs, Forex, and Spread bets, it is possible to lose more than your initial deposit.


Verona Pharma Plc Ord 0.1P

Verona Pharma is listed in the FTSE AIM All-Share
Verona Pharma is part of the Pharmaceuticals & Biotechnology sector






Share Price SpacerPrice
3.40

Share Price SpacerBid
3.30

Share Price SpacerAsk
3.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
821,302

Share Price SpacerOpen
3.45

Share Price SpacerHigh
3.45

Share Price SpacerLow
3.40

Share Price SpacerClose
3.40

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 1,009.92m £34.34m 30,000

52 Week High 3.78 52 Week High Date 23-APR-2015
52 Week Low 1.05 52 Week Low Date 31-OCT-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
19 743,136 73,166 -4.595 -0.74 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

05-May-15
16:23:49
3.30
19,900
Sell* 
3.30
3.50
656.70
Trade Type:
Ordinary

05-May-15
15:15:27
3.305
1,406
Sell* 
3.30
3.50
46.47
Trade Type:
Ordinary

05-May-15
13:52:09
3.40
5,000
 
3.30
3.50
170.00
Trade Type:
Ordinary


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Verona Pharma trades >>

Directors Deals for Verona Pharma (VRP)
Trade DateActionNotifierPriceCurrencyAmountHolding
03-Mar-15Buy
Trade Notifier Information for Verona Pharma
David Ebsworth held the position of Non-Executive Chairman at Verona Pharma at the time of this trade.
 David Ebsworth
2.43GBX450,0003279774
03-Mar-15Buy
Trade Notifier Information for Verona Pharma
Biresh Roy held the position of CFO at Verona Pharma at the time of this trade.
 Biresh Roy
2.43GBX250,000750000
16-Feb-15Buy
Trade Notifier Information for Verona Pharma
Biresh Roy held the position of CFO at Verona Pharma at the time of this trade.
 Biresh Roy
2.3GBX500,000500000
View more Verona Pharma directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Tue 16:45
corbine
and
3.40
No Opinion

Today is world Asthma day..(apparently) http://www.ginasthma.org/documents/14
Tue 16:41
corbine
re rns
3.40
No Opinion

worth reading carefully the note to editors at bottom of rns - last para! :-) imo variants of 554 to follow.......
Tue 16:17
avfc1953
Advance Notice of Results
3.40
No Opinion

Financial figures will probably look poor but hopefully there will be some good news also
Mon 21:14
brodie75
Glycopyrronium
3.45
No Opinion

Glycopyrronium Doesn't it have some adverse side effects??anyone?
Mon 19:57
moneybags1
VRP554 + Glycopyrronium
3.45
No Opinion

Glycopyrronium = Seebri made by Novartis. Very Interesting.
Mon 12:50
Armyboy1
Corbine
3.45
No Opinion

Well all we have had this year so far is good positive news and good progression with 554. It can't go wrong now can it !!!!!

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Verona Pharma (VRP) >>
Please Login or Register to post messages






Sign up for Live Prices


CD02WL.001.081313


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.